# US 2022/0091136 A1 · Early detection marker for degenerative osteoarthritis with trim24-rip3 axis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0091136 A1
- Document ID: US20220091136A1
- Status: Published application
- Kind: A1
- Application number: 17/475,753
- Filed: 2021-09-15
- Published: 2022-03-24
- Earliest claimed: 2020-09-16
- Assignees: Ajou University Industry-Academic Cooperation Foundation
- Applicants: Ajou University Industry-Academic Cooperation Foundation
- Inventors: You-Sun KIM; Siyoung YANG
- Web page: https://patentgrep.com/patent/US20220091136A1

## CPC

- G01N 33/6893: {related to diseases not provided for elsewhere}
- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q 2600/136: Screening for pharmacological compounds
- C12Q 2600/158: Expression markers
- G01N 2500/00: Screening for compounds of potential therapeutic value
- G01N 2800/105: Osteoarthritis, e.g. cartilage alteration, hypertrophy of bone
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Disclosed is the novel use of TRIM24 and RIP3 as biomarkers for diagnosing osteoarthritis, in which it is first identified that TRIM24 and RIP3 can be used as biomarkers for diagnosing osteoarthritis by confirming the tendency of TRIM24 expression to decrease and RIP3 expression to increase at the onset of osteoarthritis. These two proteins are useful in confirming the change in the expression level from the onset of osteoarthritis, thus enabling early diagnosis of osteoarthritis and effectively blocking the progression of osteoarthritis at an early stage.

## Claims

### Claim at position 1

-8. (canceled)

### Claim 9

A method for diagnosing osteoarthritis comprising an agent for measuring an expression or activity level of at least one of TRIM24 and RIP3,
wherein the agent is a primer that specifically binds to a polynucleotide encoding TRIM24 or a polynucleotide encoding RIP3,
wherein the primer comprises the sequence of SEQ ID NO: 5, 19, 25 or 26.

### Claim 10 (depends on 9)

The method according to claim 9, wherein TRIM24 comprises the amino acid sequence of SEQ ID NO: 27.

### Claim 11 (depends on 9)

The method according to claim 9, wherein RIP3 comprises the amino acid sequence of SEQ ID NO: 28.

### Claim 12

A kit for diagnosing osteoarthritis comprising an agent for measuring an expression or activity level of at least one of TRIM24 and RIP3,
wherein the agent is a primer that specifically binds to a polynucleotide encoding TRIM24 or a polynucleotide encoding RIP3,
wherein the primer comprises the sequence of SEQ ID NO: 5, 19, 25 or 26.

### Claim 13 (depends on 12)

The kit according to claim 12, wherein the kit is a PCR assay kit.

### Claim 14

A method of screening a material for preventing or treating osteoarthritis, comprising:
(a) treating a cell with a candidate material for preventing or treating osteoarthritis; and
(b) selecting a material that performs at least one of an increase in expression of TRIM24 and a decrease in expression of RIP3 in the cell as a material for preventing or treating osteoarthritis.
